Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endari PK and Safety in Sickle Cell Disease
NCT04684381Phase 4Completed
- Start
- Jan 2021
- Primary completion
- Jun 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of glutamine in sickle cell disease (SCD). Started Jan 2021; status: completed.
02
Drugs
glutamine
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT04684381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04684381.